OC-01 Nasal Spray

varenicline · Oyster Point Pharma, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for OC-01 Nasal Spray, covering 2021-10-25 to 2024-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy [Phase 2]